Myofibroblast induction with transforming growth factor-β1 and -β3 in cutaneous fetal excisional wounds
Myofibroblast induction with transforming growth factor-β1 and -β3 in cutaneous fetal excisional wounds
复制标题
DOI:
10.1016/s0022-3468(00)90007-1
复制
发表时间:
2000-02-01
影响因子:
2.4
通讯作者:
Haynes, JH
中科院分区:
文献类型:
--
作者:
Lanning, DA;Diegelmann, RF;Haynes, JH
Background/Purpose: In a noncontractile fetal rabbit model, the authors recently have shown the induction of excisional wound contraction with sustained-release cellulose implants formulated with transforming growth factor (TGF)-beta. The purpose of this study was to test the hypothesis that the excisional wound contraction in this model is associated with the induction of myofibroblasts in the surrounding dermis, demonstrated by the presence of alpha-smooth muscle actin.Methods: Cellulose discs were formulated with either 1.0 mu g of TGF-beta(1) (n = 6); 1.0 mu g of TGF-beta(3) (n = 9); 10 mu g of TGF-beta(3) (n = 6); or their carrier protein, bovine serum albumin (BSA; n = 9), for sustained-release over 5 days. Each disc was implanted into a subcutaneous pocket on the back of a fetal New Zealand White rabbit in utero on day 24 of gestation (term, 31 days). A full-thickness, 3-mm excisional wound (7.4 mm(2)) was then made next to the implanted cellulose disc. All fetuses were harvested at 3 days. The amount of alpha-smooth muscle (SM) actin in the dermis around the implants and wounds was determined using immunohistochemical techniques.Results: Excisional wounds exposed to 1.0 mu g of TGF-beta(1) (5.6 +/- 2.0 mm(2)), 1.0 mu g of TGF-beta(3) (6.9 +/- 1.0 mm(2)), and 10 mu g of TGF-beta(3) (2.7 +/- 1.0 mm(2)) were significantly smaller when compared with the BSA control group (12.8 +/- 1.1 mm(2); P